Rare diseases
Investigational molecules
Locations
290 conditions with trials, the busiest first
1 641 trials across Europe, recruiting first
Study on Anifrolumab and Phototherapy for Adults with Progressive Vitiligo
FranceStudy of emapalumab in children and adults with Macrophage Activation Syndrome (MAS) occurring in Still's Disease or Systemic Lupus Erythematosus
CzechiaStudy on Masitinib for Patients with Severe Mast Cell Activation Syndrome Unresponsive to Treatment
FranceStudy on Long-Acting Cabotegravir and Lenacapavir for HIV Patients: Evaluating Dual Antiretroviral Therapy
FranceComparison of Post-Transplant Cyclophosphamide versus Anti-T Lymphocyte Immunoglobulin for Prevention of Graft versus Host Disease in Patients Receiving Unrelated Donor Transplantation
GermanyStudy on the Effects of Tamuzimod in Patients with Moderate to Severe Ulcerative Colitis
BulgariaStudy on the Safety and Effects of Berotralstat for Children Aged 2 to 12 with Hereditary Angioedema (HAE)
AustriaStudy on the Effects of Sonelokimab for Patients with Moderate-to-Severe Palmoplantar Pustulosis
GermanyLong-term safety study of dexpramipexole tablets in patients with severe eosinophilic asthma who completed EXHALE-2 or EXHALE-3 trials
BulgariaEvaluation of fenofibrate treatment on beta cell function in children and adolescents newly diagnosed with type 1 diabetes
PolandStudy of Efgartigimod PH20 SC for Adults with Thyroid Eye Disease
AustriaStudy of Efgartigimod for Adults with Thyroid Eye Disease
BelgiumThe therapies tested most often in Immune system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
